Source:http://linkedlifedata.com/resource/pubmed/id/18751892
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2009-3-20
|
pubmed:abstractText |
NMDA receptor is involved in synaptic plasticity, learning, memory and neurological diseases like epilepsia and it is the major mediator of excitotoxicity. NR2B-containing NMDA receptors may be playing a crucial role in epileptic disorders. In the present study the effect of the convulsant drug 3-mercaptopropionic acid (MP) repetitive administration (4-7 days) on the hippocampal NR2B subunit was studied. A significant decrease in NR2B in the whole hippocampus was observed after MP4 with a tendency to recover to normal values in MP7 by western blot assay. Immunohistochemical studies showed a decrease in several CA1 and CA2/3 strata (21-73%). MP7 showed a reversion of the drop observed at 4 days in stratum oriens, pyramidal cell layer in CA1, CA2/3 and CA1 stratum radiatum. A significant fall in the lacunosum molecular layer of both areas and stratum radiatum of CA2/3 was observed. The immunostaining in MP4 showed a decrease in the granulare layer from dentate gyrus (20%), in hillus (71%) and subicullum (63%) as compared with control and these decreases were similar at MP7 values. Results showed decreases in NR2B subunit expression in different areas following repeated MP-induce seizures, suggesting that NR2B expression is altered depending on the diverse hippocampal input and output signals of each region that could be differently involved in modulating MP-induced hyperactivity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/3-Mercaptopropionic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Convulsants,
http://linkedlifedata.com/resource/pubmed/chemical/NR2B NMDA receptor,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Subunits,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, N-Methyl-D-Aspartate
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1573-6903
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
819-26
|
pubmed:meshHeading |
pubmed-meshheading:18751892-3-Mercaptopropionic Acid,
pubmed-meshheading:18751892-Animals,
pubmed-meshheading:18751892-Convulsants,
pubmed-meshheading:18751892-Hippocampus,
pubmed-meshheading:18751892-Immunohistochemistry,
pubmed-meshheading:18751892-Male,
pubmed-meshheading:18751892-Protein Subunits,
pubmed-meshheading:18751892-Rats,
pubmed-meshheading:18751892-Rats, Wistar,
pubmed-meshheading:18751892-Receptors, N-Methyl-D-Aspartate,
pubmed-meshheading:18751892-Seizures
|
pubmed:year |
2009
|
pubmed:articleTitle |
The NMDAR subunit NR2B expression is modified in hippocampus after repetitive seizures.
|
pubmed:affiliation |
Instituto de Biología Celular y Neurociencia Prof Eduardo De Robertis, Facultad de Medicina, Universidad de Buenos Aires y Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|